Nuo Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
NUO THERAPEUTICS, INC. has filed a Definitive Additional Materials proxy statement with the SEC.
OQB
Nuo Therapeutics, Inc. will hold its Annual Meeting to elect directors, ratify auditors, and vote on executive compensation, following a period of financial recovery and capital raises.